Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 607 books (2453 items)

2.
Emerging Approaches to Diagnosis and Treatment of Non–Muscle-Invasive Bladder Cancer [Internet].

Emerging Approaches to Diagnosis and Treatment of Non–Muscle-Invasive Bladder Cancer [Internet].

Chou R, Buckley D, Fu R, et al.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Oct. (Comparative Effectiveness Reviews, No. 153.)

3.
4.
Endotext [Internet].

Endotext [Internet].

De Groot LJ, Chrousos G, Dungan K, et al., editors.

South Dartmouth (MA): MDText.com, Inc.; 2000-.

5.
6.
Holland-Frei Cancer Medicine. 6th edition.

Holland-Frei Cancer Medicine. 6th edition.

Kufe DW, Pollock RE, Weichselbaum RR, et al., editors.

Hamilton (ON): BC Decker; 2003.

7.
Molecular Imaging and Contrast Agent Database (MICAD) [Internet].

Molecular Imaging and Contrast Agent Database (MICAD) [Internet].

Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.

8.
Prostate-Specific Antigen-Based Screening for Prostate Cancer: An Evidence Update for the U.S. Preventive Services Task Force [Internet].

Prostate-Specific Antigen-Based Screening for Prostate Cancer: An Evidence Update for the U.S. Preventive Services Task Force [Internet].

Lin K, Croswell JM, Koenig H, et al.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Oct. (Evidence Syntheses, No. 90.)

9.
Malaria and Some Polyomaviruses (SV40, BK, JC, and Merkel Cell Viruses).

Malaria and Some Polyomaviruses (SV40, BK, JC, and Merkel Cell Viruses).

IARC Working Group on the Evaluation of Carcinogenic Risk to Humans.

Lyon (FR): International Agency for Research on Cancer; 2013. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 104.)

10.
Glioblastoma [Internet].

Glioblastoma [Internet].

De Vleeschouwer S, editor.

Brisbane (AU): Codon Publications; 2017 Sep 27.

11.
Ovarian Cancers: Evolving Paradigms in Research and Care.

Ovarian Cancers: Evolving Paradigms in Research and Care.

Committee on the State of the Science in Ovarian Cancer Research; Board on Health Care Services; Institute of Medicine; National Academies of Sciences, Engineering, and Medicine.

Washington (DC): National Academies Press (US); 2016 Apr 25.

12.
Biologic Markers in Urinary Toxicology.

Biologic Markers in Urinary Toxicology.

National Research Council (US) Subcommittee on Biologic Markers in Urinary Toxicology.

Washington (DC): National Academies Press (US); 1995.

13.
Evolution of Translational Omics: Lessons Learned and the Path Forward.

Evolution of Translational Omics: Lessons Learned and the Path Forward.

Committee on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials; Board on Health Care Services; Board on Health Sciences Policy; Institute of Medicine; Micheel CM, Nass SJ, Omenn GS, editors.

Washington (DC): National Academies Press (US); 2012 Mar 23.

14.
Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction.

Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction.

Institute of Medicine (US) Committee to Assess the Science Base for Tobacco Harm Reduction; Stratton K, Shetty P, Wallace R, et al., editors.

Washington (DC): National Academies Press (US); 2001.

15.
Biomarker Tests for Molecularly Targeted Therapies: Key to Unlocking Precision Medicine.

Biomarker Tests for Molecularly Targeted Therapies: Key to Unlocking Precision Medicine.

Committee on Policy Issues in the Clinical Development and Use of Biomarkers for Molecularly Targeted Therapies; Board on Health Care Services; Institute of Medicine; National Academies of Sciences, Engineering, and Medicine; Graig LA, Phillips JK, Moses HL, editors.

Washington (DC): National Academies Press (US); 2016 Jun 30.

16.
Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease.

Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease.

Institute of Medicine (US) Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease; Micheel CM, Ball JR, editors.

Washington (DC): National Academies Press (US); 2010.

17.
Bitumens and Bitumen Emissions, and Some N- and S-Heterocyclic Polycyclic Aromatic Hydrocarbons.

Bitumens and Bitumen Emissions, and Some N- and S-Heterocyclic Polycyclic Aromatic Hydrocarbons.

IARC Working Group on the Evaluation of Carcinogenic Risk to Humans.

Lyon (FR): International Agency for Research on Cancer; 2013. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 103.)

18.
A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program.

A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program.

Institute of Medicine (US) Committee on Cancer Clinical Trials and the NCI Cooperative Group Program; Nass SJ, Moses HL, Mendelsohn J, editors.

Washington (DC): National Academies Press (US); 2010.

19.
Monitoring Metabolic Status: Predicting Decrements in Physiological and Cognitive Performance.

Monitoring Metabolic Status: Predicting Decrements in Physiological and Cognitive Performance.

Institute of Medicine (US) Committee on Metabolic Monitoring for Military Field Applications.

Washington (DC): National Academies Press (US); 2004.

20.
Biologic Markers in Immunotoxicology.

Biologic Markers in Immunotoxicology.

National Research Council (US) Subcommittee on Immunotoxicology.

Washington (DC): National Academies Press (US); 1992.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center